Medindia

Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Dec. 16 Anesiva,Inc. (Nasdaq: ANSV) today announced top-line results showing that the Phase 3trial evaluating Adlea(TM), its long-acting, non-opioid analgesic ...
FierceBiotech

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results

Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring Conference Call Scheduled for November 11, 2008 at 9:00 am ET; Cuts 15 Employees ...
Medindia

Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Sept. 13 Anesiva,Inc. (Nasdaq: ANSV) today announced that it has initiated a new Phase 2 studyof Adlea(TM) (formerly 4975) for the relief of post-operative pain in ...
Reuters

Anesiva's pain drug meets main goal; shares zoom

BANGALORE (Reuters) - Anesiva Inc's experimental pain drug Adlea met the main goal of a late-stage trial, raising hopes that the tiny biopharmaceutical company may find a partner to further develop ...
Houston Public Media

Hot Pepper Pain Relief

The drug, Adlea is in Phase 3 clinical trials, just prior to FDA review. And Dr. Minkowitz says his studies are blinded, so he doesn’t know which patients received Adlea and which received a placebo.
Fierce Healthcare

Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application

Adlea is a long-acting, non-opioid drug with the potential to provide pain relief for weeks to months after a single localized treatment. Its novel mechanism of action results in site-specific ...
Finanznachrichten

Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea (formerly 4975) in Osteoarthritis of the Knee

SOUTH SAN FRANCISCO, Calif., July 2 /PRNewswire-FirstCall/ -- Anesiva, Inc. today announced preliminary longer-term, follow-up results from a Phase 2 study showing ...
FierceBiotech

Anesiva, Inc. Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV - News) today announced top-line results showing that the Phase 3 trial ...
Reuters

Anesiva announces Phase 2 data showing substantial, long-term pain reductions with Adlea in osteoarthritis of the knee

Co announces preliminary longer-term, follow-up results from a Phase 2 study showing that a 1mg treatment with Adlea in patients with moderate-to-severe osteoarthritis of the knee produced substantial ...
Finanznachrichten

Anesiva Initiates New Phase 2 Trial of Adlea for Pain Relief Following Knee Replacement Surgery

SOUTH SAN FRANCISCO, Calif., Sept. 13 /PRNewswire-FirstCall/ -- Anesiva, Inc. today announced that it has initiated a new Phase 2 study of Adlea(TM) (formerly 4975 ...